Related Experiment Video
Updated: Aug 21, 2026

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
Published on: October 13, 2023
Prevention and therapy of colorectal cancer
Ernest T Hawk1, Asad Umar, Ellen Richmond
1Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA. eh51p@nih.gov
Abstract:
Colorectal cancer is expected to affect more than 146,000 and kill more than 57,000 Americans in 2004. Increased understanding of carcinogenesis is transforming clinical approaches to all stages of this disease. During the last 5 years, four new drugs have been approved for colorectal cancer treatment, and substantial progress has been made in identifying and developing agents that prevent or delay carcinogenesis. These advances substantiate target-driven approaches to cancer prevention and treatment, and provide fruitful opportunities for future investigations.
Insights
Colorectal cancer treatment is advancing with new drugs and prevention strategies. Understanding carcinogenesis offers new target-driven approaches for future cancer research and patient care.
Area of Science:
- Oncology
- Cancer Biology
- Clinical Medicine
Background:
- Colorectal cancer (CRC) poses a significant public health challenge, with high incidence and mortality rates.
- Advances in understanding the biological mechanisms of carcinogenesis are driving innovation in cancer management.
- The last five years have seen significant progress in CRC treatment and prevention.
Purpose of the Study:
- To review recent advancements in colorectal cancer (CRC) treatment and prevention.
- To highlight the impact of increased understanding of carcinogenesis on clinical approaches.
- To identify opportunities for future research in targeted cancer therapies.
Main Methods:
- Review of recent clinical advancements and drug approvals for CRC.
- Analysis of progress in identifying and developing chemopreventive agents.
- Synthesis of current knowledge on target-driven approaches in oncology.
Main Results:
- Four new drugs have been approved for colorectal cancer treatment in the past five years.
- Substantial progress has been made in identifying agents to prevent or delay carcinogenesis.
- Target-driven strategies are proving effective in cancer prevention and treatment.
Conclusions:
- Increased understanding of carcinogenesis is transforming all stages of colorectal cancer management.
- New therapeutic agents and preventive strategies offer improved outcomes for patients.
- Future research holds promise for further advancements in personalized cancer therapies.
More Related Videos
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Preventive Healthcare Services
Drugs for Treatment of Ulcerative Colitis in IBD
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: